Literature DB >> 12928591

Dietary iron restriction increases plaque stability in apolipoprotein-e-deficient mice.

Hsueh-Te Lee1, Li-Li Chiu, Tzong-Shyuan Lee, Hui-Ling Tsai, Lee-Young Chau.   

Abstract

Accumulative evidence has supported the role of iron in the development of atherosclerosis. To test whether iron-mediated oxidative stress influences plaque stability, apoliporotein-E (ApoE)-deficient mice (3 months old) were placed on a chow diet or a low-iron diet for 3 months, and the abundance of interstitial collagen and the expression of the matrix degradation-associated enzyme, matrix metalloproteinase-9 (MMP-9), in vascular lesions were assessed. A low-iron diet appeared to reduce iron deposition while substantially increasing collagen content of lesions in mice. Immunostaining demonstrated lower expression of MMP-9 in lesions of iron-restricted animals. Likewise, SDS-PAGE zymography revealed lower gelatinolytic activities in aortic tissues and sera of the same group of animals. When older ApoE-deficient mice (5 months old) received a low-iron diet for 2 months, development of the lesion area was not significantly affected. However, the lesional collagen content was much higher in the iron-restricted group of animals, and MMP-9 expression in aortic tissues from the same group of mice was significantly lower. Treatment of murine J774 macrophages with increasing concentrations of ferric ammonium citrate significantly enhanced the amount of MMP-9 secreted. Together, these data indicate that decreased vascular iron content following dietary iron restriction in ApoE-deficient mice leads to lower matrix degradation capacity and increased plaque stability. Copyright 2003 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928591     DOI: 10.1007/bf02256112

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  7 in total

1.  Testing the iron hypothesis in a mouse model of atherosclerosis.

Authors:  Léon Kautz; Victoria Gabayan; Xuping Wang; Judy Wu; James Onwuzurike; Grace Jung; Bo Qiao; Aldons J Lusis; Tomas Ganz; Elizabeta Nemeth
Journal:  Cell Rep       Date:  2013-12-05       Impact factor: 9.423

Review 2.  Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease.

Authors:  Qurat-ul-ain Jelani; Stuart D Katz
Journal:  Cardiol Rev       Date:  2010 Sep-Oct       Impact factor: 2.644

3.  Elucidation of the effects of a high fat diet on trace elements in rabbit tissues using atomic absorption spectroscopy.

Authors:  Mohamed Anwar K Abdelhalim; Hisham A Alhadlaq; Sherif Abdelmottaleb Moussa
Journal:  Lipids Health Dis       Date:  2010-01-12       Impact factor: 3.876

Review 4.  Iron deficiency anemia in heart failure.

Authors:  Natasha P Arora; Jalal K Ghali
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

Review 5.  Atherogenesis and iron: from epidemiology to cellular level.

Authors:  Francesca Vinchi; Martina U Muckenthaler; Milene C Da Silva; György Balla; József Balla; Viktória Jeney
Journal:  Front Pharmacol       Date:  2014-05-05       Impact factor: 5.810

6.  Iron Metabolism Markers and Lower Extremity Arterial Disease in People with Type 2 Diabetes.

Authors:  Hua Jin; Peihong Chen; Shan Zhang; Ping Wu; Xuemei Yu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-10-11       Impact factor: 3.249

Review 7.  Non-Transferrin-Bound Iron in the Spotlight: Novel Mechanistic Insights into the Vasculotoxic and Atherosclerotic Effect of Iron.

Authors:  Francesca Vinchi
Journal:  Antioxid Redox Signal       Date:  2021-03-22       Impact factor: 8.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.